Regeneron Pharmaceuticals Inc. (REGN) Declined -5.28% or -18.1 To Price $324.57 On Tuesday

Regeneron Pharmaceuticals Inc. (REGN) declined -5.28% or -18.1 to $324.57. It is approximately 1.40 million shares traded, which is 134.82% compare to the average total volume 1.04 million. The market cap of REGN is $34.96 billion. The year to date change is -10.44%. The 52 week price range is from $314.99 to $543.55. Price of REGN have changed 1.14% during last week. It have changed -6.62% over last month, -12.94% over last 3 months, -27.79% over last 6 months and -8.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for REGN is 371.93. It is 14.59% above current price. The 200-day Moving Averages for REGN is 434.10. It is 33.75% above current price. The 52-week High is 543.55. It is 67.47% from the current price. The 52-week Low is 314.99. It is -2.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of REGN is 2.37 on 2018-01-31. Short % to float is 1.83%. There are some statistics of REGN. It is has market cap $34.96 billion. The share outstanding is 107.70 million. The average volume is 1.04 million. The revenue is 5.87B. It has 5.36B cash and 2.81B in debt. The gross profit is 5.48B. The percent of top 15 Institution holding is 90.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of REGN is 22.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of REGN is 15.23%.


Share this post